LRRC29 Products

Antibodies
LRRC29 Antibody
LRRC29 Antibody
NBP1-83919
Species: Hu, Mouse
Applications: WB, ICC/IF, IHC, IHC-P
Host: Rabbit Polyclonal
LRRC29 Antibody
LRRC29 Antibody
H00026231-B01P
Species: Hu
Applications: WB, ELISA
Host: Mouse Polyclonal
Lysates
LRRC29 Overexpression Lysate ...
LRRC29 Overexpression Lysate (Native)
NBP2-08927
Applications: WB
LRRC29 Overexpression Lysate ...
LRRC29 Overexpression Lysate (Native)
NBL1-12684
Applications: WB
LRRC29 Overexpression Lysate ...
LRRC29 Overexpression Lysate (Dena...
H00026231-T01
Species: Hu
Applications: WB
Proteins
LRRC29 Recombinant Protein
LRRC29 Recombinant Protein
H00026231-P01
Species: Hu
Applications: WB, ELISA, PA
LRRC29 Partial Recombinant Pr ...
LRRC29 Partial Recombinant Protein
H00026231-Q01
Species: Hu
Applications: WB, ELISA, PA
LRRC29 Recombinant Protein An ...
LRRC29 Recombinant Protein Antigen
NBP1-83919PEP
Species: Hu
Applications: AC

Description

LRRC29, also known as Leucine-rich repeat-containing protein 29, is a 23.8 kDa, 223 amino acid protein that is involved in promoting the ubiquitination and degradation of phosphorylated proteins. There is currently no research being conducted to link this protein to diseases. The protein interacts with CHRM3, HSPG2, AKR1C3, HHLA3, and PCDH15 proteins.

Bioinformatics

Entrez Human
Uniprot Human
Human
Human
Human
Human
Product By Gene ID 26231
Alternate Names
  • F-box/LRR-repeat protein 9
  • leucine-rich repeat-containing protein 29
  • F-box protein FBL9
  • FBL9F-box and leucine-rich repeat protein 9FBXL9
  • leucine rich repeat containing 29

Diseases related to LRRC29

Discover more about diseases related to LRRC29.

Haploinsufficiency
Malignant Neoplasms
Neoplasms
Malignant Neoplasm Of Breast
Mammary Neoplasms

PTMs for LRRC29

Learn more about PTMs related to LRRC29.

Methylation

Bioinformatics Tool for LRRC29

Discover related pathways, diseases and genes to LRRC29. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.